Speaker illustration

Doctor Ke Xu

Shanghai Chest Hospital, Shanghai (China)

Member of:

EAPCI

PEAR1 rs12041331 polymorphisms and the risk of adverse cardiovascular outcomes in patients with acute coronary syndrome and/or percutaneous coronary intervention: a systematic review and meta-analysis

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Pharmacogenetics

Session: Pharmacology and Pharmacotherapy ePosters

Thumbnail

Genetic polymorphisms and cardiovascular outcomes in Chinese patients undergoing PCI and treated with clopidogrel and aspirin

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Pharmacogenetics

Session: Pharmacology and Pharmacotherapy ePosters

Thumbnail

Association of CYP2C19*2 and PEAR1 gene variant with platelet reactivity and clinical outcomes in patients undergoing stenting and treated with aspirin and clopidogrel

Event: ESC Congress 2018

Topic: Pharmacogenetics

Session: Pharmacogenetics - New sights on the horizon

Thumbnail

PEAR1 rs12041331 polymorphisms and the risk of adverse cardiovascular outcomes in patients with acute coronary syndrome and/or percutaneous coronary intervention: a systematic review and meta-analysis

Event: ESC Asia with APSC & AFC 2020

Topic: Pharmacogenetics

Session: Abstract Programme

Thumbnail

This platform is supported by

logo Novo Nordisk